Overview

The Effect of Combination Lumacaftor and Ivacaftor on Markers of Hyperglycemia

Status:
Terminated
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to find out if the combined therapy lumacaftor-ivacaftor affects glycemia in patient with cystic fibrosis.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Ivacaftor